183 related articles for article (PubMed ID: 32738133)
1. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer.
Thomas-Teinturier C; Oliver-Petit I; Pacquement H; Fresneau B; Allodji RS; Veres C; Bolle S; Berchery D; Demoor-Goldschmidt C; Haddy N; Diallo I; de Vathaire F
Eur J Endocrinol; 2020 Oct; 183(4):471-480. PubMed ID: 32738133
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
[TBL] [Abstract][Full Text] [Related]
3. Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.
Swerdlow AJ; Cooke R; Beckers D; Butler G; Carel JC; Cianfarani S; Clayton P; Coste J; Deodati A; Ecosse E; Hokken-Koelega ACS; Khan AJ; Kiess W; Kuehni CE; Flück CE; Pfaffle R; Sävendahl L; Sommer G; Thomas M; Tidblad A; Tollerfield S; Zandwijken GRJ
J Clin Endocrinol Metab; 2019 Mar; 104(3):658-664. PubMed ID: 30137467
[TBL] [Abstract][Full Text] [Related]
4. GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution.
Brignardello E; Felicetti F; Castiglione A; Fortunati N; Matarazzo P; Biasin E; Sacerdote C; Ricardi U; Fagioli F; Corrias A; Arvat E
J Endocrinol Invest; 2015 Feb; 38(2):171-6. PubMed ID: 25344310
[TBL] [Abstract][Full Text] [Related]
5. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
[TBL] [Abstract][Full Text] [Related]
6. Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.
Felicetti F; Fortunati N; Garbossa D; Biasin E; Rudà R; Daniele D; Arvat E; Corrias A; Fagioli F; Brignardello E
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1277-82. PubMed ID: 25609074
[TBL] [Abstract][Full Text] [Related]
7. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
[TBL] [Abstract][Full Text] [Related]
8. Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors.
Pollock NI; Cohen LE
Front Endocrinol (Lausanne); 2021; 12():745932. PubMed ID: 34745010
[TBL] [Abstract][Full Text] [Related]
9. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer.
Withrow DR; Anderson H; Armstrong GT; Hawkins M; Journy N; Neglia JP; de Vathaire F; Tucker MA; Inskip PD; Brenner AV; Stovall MA; Diallo I; Berrington de Gonzalez A; Veiga LHS
JAMA Oncol; 2022 Dec; 8(12):1756-1764. PubMed ID: 36201196
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.
Ergun-Longmire B; Mertens AC; Mitby P; Qin J; Heller G; Shi W; Yasui Y; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3494-8. PubMed ID: 16822820
[TBL] [Abstract][Full Text] [Related]
11. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
[TBL] [Abstract][Full Text] [Related]
12. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.
Sklar CA; Mertens AC; Mitby P; Occhiogrosso G; Qin J; Heller G; Yasui Y; Robison LL
J Clin Endocrinol Metab; 2002 Jul; 87(7):3136-41. PubMed ID: 12107213
[TBL] [Abstract][Full Text] [Related]
13. High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia.
Goshen Y; Stark B; Kornreich L; Michowiz S; Feinmesser M; Yaniv I
Pediatr Blood Cancer; 2007 Sep; 49(3):294-7. PubMed ID: 17243137
[TBL] [Abstract][Full Text] [Related]
14. Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.
Bowers DC; Moskowitz CS; Chou JF; Mazewski CM; Neglia JP; Armstrong GT; Leisenring WM; Robison LL; Oeffinger KC
J Clin Oncol; 2017 May; 35(14):1570-1576. PubMed ID: 28339329
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study.
Journy NMY; Zrafi WS; Bolle S; Fresneau B; Alapetite C; Allodji RS; Berchery D; Haddy N; Kobayashi I; Labbé M; Pacquement H; Pluchart C; Schwartz B; Souchard V; Thomas-Teinturier C; Veres C; Vu-Bezin G; Diallo I; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):133-141. PubMed ID: 33033142
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
17. Are radiation-induced cavernomas clinically relevant findings? Results from long-term follow-up with brain magnetic resonance imaging of childhood cancer survivors.
Becker L; Gebauer J; Küchler J; Staackmann C; Schacht H; Lauten M; Jensen-Kondering U; Schramm P; Langer T; Neumann A
Radiol Oncol; 2021 Aug; 55(3):274-283. PubMed ID: 34384013
[TBL] [Abstract][Full Text] [Related]
18. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Neglia JP; Robison LL; Stovall M; Liu Y; Packer RJ; Hammond S; Yasui Y; Kasper CE; Mertens AC; Donaldson SS; Meadows AT; Inskip PD
J Natl Cancer Inst; 2006 Nov; 98(21):1528-37. PubMed ID: 17077355
[TBL] [Abstract][Full Text] [Related]
19. Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
Wang Z; Wilson CL; Easton J; Thrasher A; Mulder H; Liu Q; Hedges DJ; Wang S; Rusch MC; Edmonson MN; Levy S; Lanctot JQ; Caron E; Shelton K; Currie K; Lear M; Patel A; Rosencrance C; Shao Y; Vadodaria B; Yergeau D; Sapkota Y; Brooke RJ; Moon W; Rampersaud E; Ma X; Chang TC; Rice SV; Pepper C; Zhou X; Chen X; Chen W; Jones A; Boone B; Ehrhardt MJ; Krasin MJ; Howell RM; Phillips NS; Lewis C; Srivastava D; Pui CH; Kesserwan CA; Wu G; Nichols KE; Downing JR; Hudson MM; Yasui Y; Robison LL; Zhang J
J Clin Oncol; 2018 Jul; 36(20):2078-2087. PubMed ID: 29847298
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: A Dutch LATER study.
Verbruggen LC; Kok JL; Teepen JC; Janssens GO; de Boer CM; Stalpers LJA; Vernooij MW; van Dulmen-den Broeder E; Loonen JJ; van den Heuvel-Eibrink MM; Tissing WJE; van der Heiden-van der Loo M; Versluys AB; Neggers SJCMM; van Leeuwen FE; Hoving EW; Wesseling P; Kremer LCM; Ronckers CM; van der Pal HJH;
Eur J Cancer; 2021 Jun; 150():240-249. PubMed ID: 33934061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
